These lab-made options weren't formulated with recreational use in mind. During the nineteen nineties, John W. Huffman and also a staff of fellow chemists at Clemson College made a number of the first formulation for artificial cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impacts